Pulmonary embolism, part II: Management

Experimental and Clinical Cardiology

Volumn 18, Issue 2, 2013, Pages 139-147

  Bělohlávek, Jan ^a   Dytrych, Vladimír ^a   Linhart, Aleš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Anticoagulation; Catheter based management; Pulmonary embolism; Supportive care; Surgical embolectomy; Thrombolysis

Indexed keywords

ALTEPLASE; AMBRISENTAN; ANTIBIOTIC AGENT; BOSENTAN; BRONCHODILATING AGENT; DALTEPARIN; DOBUTAMINE; ENOXAPARIN; FONDAPARINUX; HEPARIN; LEVOSIMENDAN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; NITRIC OXIDE; NORADRENALIN; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; RETEPLASE; REVIPARIN; SILDENAFIL; STREPTOKINASE; TENECTEPLASE; TINZAPARIN; UROKINASE;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG RESPONSE; DRUG TREATMENT FAILURE; EMBOLECTOMY; EXTRACORPOREAL OXYGENATION; FIBRINOLYTIC THERAPY; HEART ARREST; HUMAN; LUNG EMBOLISM; OXYGEN THERAPY; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 84879941389     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Grignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology 1984;60:132-5.
2. Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 1999;27:540-4.
3. Gromadzinski L, Ciurzynski M, Januszko-Giergielewicz B, et al. Diagnostic value of mitral and tricuspid annular excursion in the diagnostics of acute pulmonary embolism patients with chronic heart failure. Int J Cardiol 2011;149:118-9.
4. Widimský J, Malý J, Eliáš P, et al. Doporucení pro diagnostiku a lécbu akutní plicní embolie. Vnitr. Lék 2008; 54: 1S25-1S72.
5. Torbicki A, Perrier A, Konstantidines S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2008;29:2276-315.
6. Manier G, Castaing Y. Influence of cardiac output on oxygen exchange in acute pulmonary embolism. Am Rev Respir Dis 1992;145:130-6.
7. Prewitt RM. Hemodynamic management in pulmonary embolism and acute hypoxemic respiratory failure. Crit Care Med 1990;18:S61-S69.
8. Layish DT, Tapson VF. Pharmacologic hemodynamic support in massive pulmonary embolism. Chest 1997;111:218-24.
9. Büller HR, Davidson BL, Decousus H et al. Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003;349:1695-702. (Erratum in: N Engl J Med 2004;350:423).
10. Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Results from the OASIS-5 trial. J Am Coll Cardiol 2007;50:1742-51.
11. Bailen M, Cuadra J, Aguayo H. Thrombolysis during cardiopulmonary resuscitation in fulminant pulmonary embolism: A review. Crit Care Med 2001; 29: 2211-2219.
12. Nolan JP, Soarb J, Zidemanc, et al. on behalf of the ERC Guidelines Writing Group. European Resuscitation Council Guidelines for Resuscitation 2010. Section 1. Executive summary. Resuscitation 2010;81:1219-76.
13. Bottiger B, Bode C, Kern S, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: A prospective clinical trial. Lancet 2001;357:1583-5.
14. Fatovich D, Dobb G, Cluqston R. A pilot randomised trial of thrombolysis in cardiac arrest (The TICA trial). Resuscitation 2004;61:309-13.
15. Bottiger W, Arntz HR, Chamberlain DA et al. for the TROICA Trial Investigators and the European Resuscitation Council Study Group.Thrombolysis during Resuscitation for Out-of-Hospital Cardiac Arrest. Bernd International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: The Thrombolysis in Cardiac Arrest (TROICA) Study. N Engl J Med 2008;359:2651-62.
16. Prusczyk P, Torbicki A, Kuch-Wocial A, et al. Diagnostic value of transesophageal echocardiography in suspected haemodynamically significant pulmonary embolism. Heart 2001;85:628-34.
17. Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes Garcia M, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial. J Thromb Thrombolysis 1995;2:227-9.
18. Capstick T, Henry MT. Efficacy of thrombolytic agents in the treatment of pulmonary embolism. Eur Respir J 2005;26:864-74.
19. Stein P, Henry J. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995;108:978-81.
20. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-9.
21. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry. J Am Coll Cardiol 1997;30:1165-71.
22. Dalla-Volta S, Palla A, Santolicandro A, et al. PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. J Am Coll Cardiol 1992;20:520-6.
23. Goldhaber S, Haire W, Feldstein M, et al. Alteplase versus heparin in acute pulmonary embolism: Randomised trial assessing rightventricular function and pulmonary perfusion. Lancet 1993;341:507-11.
24. Konstantinides S, Tiede N, Geibel A, et al. Comparison of alteplase Versus heparin for resolution of major pulmonary embolism. Am J Cardiol 1998;82:966-70.
25. Ribeiro A, Lindmarker P, Johnsson H, et al. Pulmonary embolism: One-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 1999;99:1325-30.
26. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pumonary embolism. N Engl J Med 2002;347:1143.
27. Tissue plasminogen activator for the treatment of acute pulmonary embolism: A collaborative study by the PIOPED Investigators. Chest 1990;97:528-33.
28. Wan S, Quinlan D, Agnelli G, et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: A meta-analysis of the randomized controlled trials. Circulation 2004;110:744-9.
29. Steering Committee. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: Rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Am Heart J 2012;163:33-8.
30. Torbicky A, Galie N, Covezzoli A, et al. Right heart thrombi in pulmonary embolism: Results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol 2003;41:2245-52.
31. Chapoutot L, Nazeyrollas P, Metz D, et al. Floating right heart thrombi and pulmonary embolism: Diagnosis, outcome and therapeutic management. Cardiology 1996;87:169-74.
32. Ferrari E, Benhamou M, Berthier F, Baudouy M. Mobile thrombi of the right heart in pulmonary embolism: Delayed disappearance after thrombolytic treatment. Chest 2005;127:1051-3.
33. Farfel Z, Shechter M, Vered Z, et al. Review of echocardiographically diagnosed right heart entrapment of pulmonary emboli-in-transit with emphasis on management. Am Heart J 1987;113:171-8.
34. Justin P, Pierard L. Management of mobile right heart thrombi: A prospective series. Int J Card 2005;99:381-8.
35. Schuchlenz H, Weihs W, Horner S, et al. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000;109:456-62.
36. Konstantinides S, Geibel A, Kasper W, et al. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998;97:1946-51.
37. Meneveau N, Schiele F, Metz D, et al. Comparative efficacy of a twohour regimen of streptokinase versus alteplase in acute pulmonary embolism: Immediate clinical and hemodynamic outcome and oneyear follow-up. J Am Coll Cardiol 1998;31:1057-63.
38. Wang CH, Zhai Z, Yang Y et al; for the China Venous Thromboembolism (VTE) study group. Half the dosage, similar efficacy, less bleeding. The new tissue plasminogen activator regimen for pulmonary embolism? Chest 2010;136:254-64.
39. Meneveau N, Seronde MF, Blonde MC, et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest 2006;129:1043-50.
40. Yalamanchili K, Fleisher AG, Lehrman SG, et al. Open pulmonary embolectomy for treatment of major pulmonary embolism. Ann Thorac Surg 2004;77:819-23.
41. Leacche M, Unic D, Goldhaber SZ, et al. Modern surgical treatment of massive pulmonary embolism: Results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg 2005;129:1018-23.
42. Kuo WT, Gould MK, Louie JD, et al. Catheter-directed therapy for the treatment of massive pulmonary embolism: Systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol 2009;20:1431-40.
43. Widimský J. Diagnostika a lécba akutní plicní embolie v roce 2010. Vnitrní lékarství 2011;57:5-21.
44. Aigner C, Wisser W, Taghavi S, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg 2007;31:468-73; discussion 473-4.
45. Berman M, Tsui S, Vuylsteke A, et al. Successful extracorporeal membrane oxygenation after pulmonary thromboendarterectony. Ann Thorac Surg 2008;86:1261-7.
46. Kawahito K, Murata S, Adachi H, et al. Resuscitation and circulatory support using extracorporeal membrane oxygenation for fulminant pulmonary embolism. Artif Organs 2000;24:427-30.
47. Misawa Y, Fuse K, Yamaguchi T, et al. Mechanical circulatory assist for pulmonary embolism. Perfusion 2000;15:527-9.
48. Gregoric ID, Chandra D, Myers TJ, et al. Extracorporeal membrane oxygenation as a bridge to emergency heart-lung transplantation in a patient with idiopathic pulmonary arterial hypertension. J Heart Lung Transplant 2008;27:466-8.
49. Belohlávek J, Rohn V, Jansa P, et al. Veno-arterial ECMO in severe acute right ventricular failure with pulmonary obstructive hemodynamic pattern. J Invasive Cardiol 2010;22:365-9.
50. Berman M, Tsui S, Vuylsteke A, et al. Life-threatening right ventricular failure in pulmonary hypertension: RVAD or ECMO? J Heart Lung Transplant 2008;27:1188-9.